Tokyo (Chugai)

Chugai Pharmaceutical Co. Ltd., headquartered in Tokyo, Japan, was established in 1925. Employing over 7'000 people Chugai is one of Japan's leading pharmaceutical companies.

With oncology, renal diseases, and bone and joint diseases as Chugai's strategic areas, there's a strong R&D focus on antibody drug development. Based on the biopharmaceutical drug development know-how accumulated so far, Chugai has been developing a unique genomic antibody-drug discovery strategy aimed at promoting even greater R&D innovation, early commercialisation and the discovery of next-generation antibody drugs. Approximately 17% of revenues are invested in research and development.